Friess Associates LLC Vericel Corp Transaction History

Friess Associates LLC

  • $59.9 Million
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$15.01 - $18.89 $1.22 Million - $1.53 Million
-81,226 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$16.23 - $20.29 $10,630 - $13,289
655 Added 0.81%
81,226 $1.42 Million
Q4 2018

Feb 14, 2019
BUY
$10.77 - $18.44 $867,749 - $1.49 Million
80,571 New
80,571 $1.4 Million

Others Institutions Holding VCEL

# of Institutions
293
Shares Held
50.7M
Call Options Held
98.2K
Put Options Held
135K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.24B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Friess Associates LLC Portfolio

Follow Friess Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Friess Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email